Biointelect and CR2O forge new strategic partnership to provide advanced end-to-end commercialisation solutions for the life science sector globally

Driving more efficient and accelerated results from pre-clinical trials to commercialisation of new therapies for Australian, European and U.S. firms. The full innovation journey offering for Biointelect, a strategic life science consulting company, and CR2O, a leading contract research organisation, has reached new heights, with Australian, European and U.S. clients now able to tap into […]

Funding Innovative Medicines Whitepaper

Australia has a unique opportunity to reform the way it evaluates and funds medicines and vaccines, toensure that Australians are among the first in the world to access new technologies. This is a policyobjective of the Australian Government that is shared by the medicines industry. Reforms to Australia’sPharmaceutical Benefits Scheme (PBS) and National Immunisation Program […]